Neuro-Oncology: The Podcast

99 Episodes

1. CSF proteomics in glioma

   Published: 3/21/2025
2. Vorasidenib in IDH mutant glioma

   Published: 3/8/2025
3. KL-50 in post TMZ MMR-deficient GBM

   Published: 2/22/2025
4. Measurable disease per FET-PET vs MRI in GBM

   Published: 2/8/2025
5. Pre-radiation chemotherapy in GBM

   Published: 1/20/2025
6. cIMPACT-NOW Update 8: grading of meningiomas

   Published: 12/13/2024
7. Residual tumor volume and survival after CCNU/TMZ in GBM

   Published: 11/24/2024
8. Alterations in RNA splicing between meningioma DNA methylation groups

   Published: 11/8/2024
9. The immune landscape of IDH mutant and IDHwt glioma

   Published: 10/25/2024
10. Equity-driven applications of AI in neuro-oncology

    Published: 10/9/2024
11. IDH mutant glioma across age groups

    Published: 9/20/2024
12. Contemporary molecular prognostic signatures in glioma

    Published: 8/30/2024
13. FDG PET in PCNSL

    Published: 8/9/2024
14. TMZ and MGMT in elderly GBM patients

    Published: 7/12/2024
15. IDH mutant glioma and IDH inhibitors

    Published: 7/5/2024
16. Leptomeningeal disease, a SNO and ASCO review

    Published: 6/28/2024
17. Cancer stems cell in GBM

    Published: 6/21/2024
18. Drug delivery across the blood-brain barrier

    Published: 6/13/2024
19. Gliomatosis cerebri in children

    Published: 5/24/2024
20. Immunotherapy drives mesenchymal shift in GBM

    Published: 5/17/2024